# Nobody's watching the boring stocks — Elevance and AT&T just beat quietly as AI doubts build

_AI-generated trading idea · BULLISH · ELV, QQQ, T_

> Canonical page: https://commonquant.ai/research/for-you/nobody-s-watching-the-boring-stocks-elevance-and-at-t-just-b--b7d3d272-9797-526c-b022-74b026e90872

Elevance raising full-year guidance and next year's outlook shows its profit rebuild in insurance is on track, and AT&T's fiber subscriber surge proves steady-demand telecom can grow even with satellite competition looming. As prominent investors openly debate whether AI stocks are a bubble and the tech-heavy indexes whipsaw, money historically rotates into reliable cash-paying businesses with fresh, confirmed earnings. These two beaten-on-headlines, strong-on-fundamentals names offer a defensive way to stay invested in stocks while the AI story sorts itself out.

## Idea

Elevance raising full-year guidance and next year's outlook shows its profit rebuild in insurance is on track, and AT&T's fiber subscriber surge proves steady-demand telecom can grow even with satellite competition looming. As prominent investors openly debate whether AI stocks are a bubble and the tech-heavy indexes whipsaw, money historically rotates into reliable cash-paying businesses with fresh, confirmed earnings. These two beaten-on-headlines, strong-on-fundamentals names offer a defensive way to stay invested in stocks while the AI story sorts itself out.

## Advanced Analysis

### Verdict: The cash-generation story checks out at AT&T, cracks at Elevance — wait for entries

The idea's thesis is half-confirmed and half-cracked. AT&T is the strongest point for it: Q2 free cash flow jumped 87.7% quarter over quarter to $5.1B and net margin expanded 2.5 points to about 14.7%, with a trailing free-cash-flow rank in the 94th percentile among Communication Services peers backing the fiber-demand story per MarketWatch. The strongest point against is Elevance's leg: free cash flow fell 60.3% to $1.6B, operating cash flow fell 55.8%, and Q4 2025's negative $209M free cash flow ranked in just the 5th percentile of 1,020 Health Care peers — a weak foundation for a "reliable cash-paying" framing. Timing-wise, the strategy itself says wait: ELV (about $439.3) trades 35.2 points above its entry EMA with RSI at 78.2, T sits $2.19 below its EMA with RSI at 27.2, and only QQQ (about $725.0, one close above roughly $726.8) is near its trigger. What would flip the verdict: an ELV Q3 print that reiterates raised guidance and confirms free cash flow rebuilding, combined with the price rule confirming entry. Trade-readiness rules are not met; the honest position is to wait for the Q3 earnings catalyst and the QQQ close above that EMA line.

#### Conviction score breakdown

Composite score computed by the server from the applicable evidence-tier dimensions.

| Measure | Value |
| --- | ---: |
| Thesis support | 55/100 |
| Trade readiness | 30/100 |
| Risk quality | 60/100 |
| Backtest evidence | 45/100 |
| Fundamentals trend | 45/100 |
| Score | 47/100 |
| Composite Score | 47/100 |
| Evidence Tier | backtested |

#### Decision scenarios

Bull, base, and bear cases synthesized from the cited evidence tier. Likelihoods are rounded evidence-weighted judgments, not statistically calibrated forecasts.

| Measure | Value |
| --- | ---: |
| Evidence Tier | backtested |

### Trade now: QQQ is one strong close away; ELV and T need pullbacks first

The strategy is waiting, not acting, on its two headline names. ELV closed at $439.3, sitting about 35.2 points above its 50-day EMA at $404.1 — the entry wants a cross up through that line from below, so price is on the wrong side. Its 14-day RSI is 78.2, far above the 45 trigger, and the price is $29.3 above the Bollinger middle band at $409.9, which the entry requires it to be below. Only the trend-strength condition (ADX of 21.7 versus the 20 floor) is met. Concretely, "wait" for ELV means a pullback to roughly the $400–$410 area that then turns back up with RSI near 45 — do not chase here.

AT&T is even further out. At $21.91 it trades $2.19 below its 50-day EMA of $24.10, and its 14-day RSI of 27.2 needs to climb to 45 before any entry — a 17.8-point gap on momentum. The stock is below the Bollinger middle at $23.86 (one condition met), but everything else says bottoming, not entry.

QQQ is the live one. At $725.01 it sits just $1.76 below its 50-day EMA of roughly $726.8, its 14-day RSI is about 44.7 versus the 45 cross, ADX (20.7) is already above 20, and price is below the Bollinger middle at $738.4. Three of four conditions are met or nearly met — a single daily close above roughly $726.8 with RSI nudging 45 arms the entry. The trade plan from there: risk is capped at a 2% loss on the position, the first profit target is +4%, and the level map puts the nearest resistance at about $729.3 with the second support near $710 below.

This is a backtested setup: over a 60-month window the ELV leg completed 9 trades at a 66.7% win rate with a maximum drawdown of 3.4% and an 8.6% return, and the tighter 24-month window produced an 8.1% return with a 3.9% drawdown. Note that no nearby-parameter robustness check was completed — the sensitivity evaluation ran out of its time budget — so trade the published rules as written rather than assuming alternate settings.

#### ELV price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | ELV |
| Timeframe | 1d |

#### QQQ price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | QQQ |
| Timeframe | 1d |

#### T price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | T |
| Timeframe | 1d |

### Fresh Earnings Confirmed, Cash Flows Rising: Why the Defensive Rotation Case Holds Up

The thesis rests on two companies that just delivered confirmed earnings news, and both legs check out against the reported fundamentals. Per Bloomberg's October 21 report, Elevance raised full-year guidance on lower medical costs — and the quarter behind that announcement shows revenue ticking up to $50.5B from $50.2B quarter over quarter, with shares outstanding shrinking another 0.2% to 216.8 million. That's a company growing the top line while returning capital, exactly the profile the idea says rotation money seeks. AT&T's leg is even stronger on the cash side. Its Q2 (ended June 30, 2026) shows free cash flow jumping 87.7% quarter over quarter to $5.1B, net income up 20.8% to $4.6B, net margin expanding 2.5 points to 14.7%, and the share count down 1.4% to 6.85 billion. Per MarketWatch's same-day piece, AT&T shrugged off SpaceX fears with a large haul of new internet subscribers — the demand confirmation the thesis needs. For context, AT&T's trailing free cash flow already ranked in the 94th percentile of its Communication Services peers. The ownership tape offers modest but real support: ELV institutional coverage (provisional, as of the September 30, 2026 report period) shows net open-market insider buying worth roughly $292K, and shares outstanding have fallen from 221.7 million a year ago to 216.8 million — a consistent buyback cadence rather than dilution. The completed backtest gives the timing overlay some support: over the 60-month window the strategy logged 9 trades with a 66.7% win rate, an 8.6% total return, and a maximum drawdown of just 3.4%.…

#### ELV Return on equity

Return on equity trend from CommonQuant fundamentals/XBRL data; -79.2% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2007-12-31 | \0.14551290973623773% |
| 2008-06-30 | \0.03531016961114117% |
| 2008-09-30 | \0.03786686845104345% |
| 2008-12-31 | \0.11621569917458716% |
| 2009-03-31 | \0.02698530779244932% |
| 2009-06-30 | \0.031164477438895607% |
| 2009-09-30 | \0.031931920550652894% |
| 2009-12-31 | \0.19087973036563932% |
| 2009-12-31 | \0.11027498361038156% |
| 2010-03-31 | \0.03575973114946654% |
| 2010-06-30 | \0.03036506168428574% |
| 2010-09-30 | \0.030338605269747184% |
| Latest Value | \0.030338605269747184% |
| Change Pct | \-79.15057480141103% |
| Ticker | ELV |
| Timeframe | reported periods |

#### ELV Revenue

Revenue trend from CommonQuant fundamentals/XBRL data; -76.2% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2007-12-31 | $61167900000 |
| 2008-06-30 | $15666800000 |
| 2008-09-30 | $14961000000 |
| 2008-12-31 | $61251100000 |
| 2009-03-31 | $15143300000 |
| 2009-06-30 | $15413200000 |
| 2009-09-30 | $15425100000 |
| 2009-12-31 | $64939500000 |
| 2009-12-31 | $19046500000 |
| 2010-03-31 | $15072900000 |
| 2010-06-30 | $14431300000 |
| 2010-09-30 | $14572300000 |
| Latest Value | $14572300000 |
| Change Pct | $-76.17655665798564 |
| Ticker | ELV |
| Timeframe | reported periods |

#### ELV sector percentile check

Ranks ELV against 1020 companies in its sector using CommonQuant fundamentals.

| Measure | Value |
| --- | ---: |
| Free cash flow | \4.6078431372549025th percentile |
| Gross margin | \87.43718592964824th percentile |
| Return on equity | \71.78807947019867th percentile |
| Operating margin | \70.28508771929825th percentile |
| Ticker | ELV |
| Sector | Health Care |
| Peer Count | 1020 |

### Scores

- **Conviction score breakdown:** 47
- **Thesis support:** 55
- **Trade readiness:** 30
- **Risk quality:** 60
- **Backtest evidence:** 45
- **Fundamentals trend:** 45

### Watch items

- **QQQ — Daily close vs 50-day EMA**
- **QQQ — Second support level**
- **ELV — Price vs 50-day EMA**
- **ELV — RSI (14)**
- **ELV — Q3 earnings (fiscal quarter ended Sept 30)**
- **ELV — Free cash flow trend**
- **ELV — Insider open-market activity**
- **T — RSI (14)**
- **T — Price vs 50-day EMA**
- **T — Fiber subscriber commentary at next earnings**

## Key details

- Symbols: ELV, QQQ, T
- Timeframes: 1d
- Tags: \#canonical-demand, \#cluster-version:1, \#direction:bullish, \#entity-kind:instrument, \#entity:ELV, \#entity:QQQ, \#entity:T, \#horizon:unspecified, \#intent:research, \#symbol:ELV, \#symbol:QQQ, \#symbol:T

## Community

- Upvotes: 0
- Views: 0
- Copies: 0
- Cosigns: 0

## News sources

- [Elevance Raises Full-Year Guidance on Lower Medical Costs](https://www.bloomberg.com/news/articles/2026-10-21/elevance-raises-full-year-guidance-on-lower-medical-costs) — Bloomberg
- [AT&T shrugs off SpaceX fears with its own large haul of new internet subscribers](https://www.marketwatch.com/story/at-t-shrugs-off-spacex-fears-with-its-own-large-haul-of-new-internet-subscribers-644f66a8?mod=mw_rss_topstories) — MarketWatch

## Related

- [ELV trade ideas](https://commonquant.ai/markets/elv)
- [QQQ trade ideas](https://commonquant.ai/markets/qqq)
- [T trade ideas](https://commonquant.ai/markets/t)
- [Latest market news](https://commonquant.ai/news)

## About CommonQuant Research

Ideas and Advanced Analysis are generated with fresh, LLM-selected news headlines and grounded in SEC XBRL fundamentals and peer percentiles. Strategies built from these ideas are automatically backtested (over a timeframe-dependent historical window with walk-forward tuning) and stress-tested before they can go live, then monitored against the news hourly while they run.